SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+24.6%
5Y CAGR+47.8%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+24.6%/yr
Annual compound
5Y CAGR
+47.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
7.1x
Strong expansion
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
202523.16+42.7%
202416.23+80.8%
20238.98-25.0%
202211.96-5.5%
202112.66+286.2%
20203.28-31.8%
20194.81-